Kramer R A, Dekker N, Egmond M R
Department of Enzymology, Centre for Biomembranes and Lipid Enzymology, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
FEBS Lett. 2000 Feb 25;468(2-3):220-4. doi: 10.1016/s0014-5793(00)01231-x.
Escherichia coli outer membrane protease OmpT has been characterised as a serine protease based on its inhibitor profile, but serine protease consensus sequences are absent. By site-directed mutagenesis we substituted all conserved serines and histidines. Substitution of His(101) and His(212) by Ala, Asn or Gln resulted in variant enzymes with 0.01 and 9-20% residual enzymatic activity towards a fluorogenic pentapeptide substrate, respectively. The mutations S140A and S201A did not decrease activity, while variants S40A and S99A yielded 0.5 and 0.2% residual activities, respectively. When measured with a dipeptide substrate the variant S40A demonstrated full activity, whereas variant S99A displayed at least 500-fold reduced activity. We conclude that Ser(99) and His(212) are essential active site residues. We propose that OmpT is a novel serine protease with Ser(99) as the active site nucleophile and His(212) as general base.
大肠杆菌外膜蛋白酶OmpT根据其抑制剂谱被鉴定为一种丝氨酸蛋白酶,但不存在丝氨酸蛋白酶共有序列。通过定点诱变,我们替换了所有保守的丝氨酸和组氨酸。用丙氨酸、天冬酰胺或谷氨酰胺替换His(101)和His(212),分别产生了对荧光五肽底物具有0.01%和9 - 20%残余酶活性的变体酶。突变S140A和S201A并未降低活性,而变体S40A和S99A分别产生了0.5%和0.2%的残余活性。当用二肽底物进行测量时,变体S40A表现出完全活性,而变体S99A的活性至少降低了500倍。我们得出结论,Ser(99)和His(212)是必需的活性位点残基。我们提出OmpT是一种新型丝氨酸蛋白酶,以Ser(99)作为活性位点亲核试剂,His(212)作为通用碱。